J Korean Pediatr Soc.  1998 Oct;41(10):1430-1432.

A Case of Inappropriate ADH Secretion Secondary to Vinblastine Therapy

Affiliations
  • 1Department of Pediatrics, College of Medicine, Yonsei University, Korea.
  • 2Department of Pediatrics, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
  • 3Department of Pediatrics, Kunpo Medical Center, College of Medicine, Wonkwang University, Kunpo, Korea.

Abstract

Inappropriate secretion of antidiuretic hormone (ADH) secondary to vincristine therapy has been reported frequently. But there has been five previous reports of vinblastine associated SIADH in the world and in 4 reports, bleomycin and cis-platinum were used along with vinblastine together. Because penetration of vinka alkaloids into CSF of humans is known to be poor, it has been suggested that lowering the osmotic threshold for vasopressin release induces SIADH in humans. In our case, the patient did not receive cis-platinum during chemotherapy. From this we concluded that vinblastine alone can induce SIADH without nephrotoxicity of cis-platinum. We experienced a case of inappropriate ADH secretion secondary to vinblastine therapy in a 5- month-old male infant who has been taking vinblastine due to Langerhans cell histiocytosis. We report this case with a brief review of related literatures.

Keyword

Vinblastine; SIADH

MeSH Terms

Alkaloids
Bleomycin
Cisplatin
Drug Therapy
Histiocytosis, Langerhans-Cell
Humans
Inappropriate ADH Syndrome
Infant
Male
Vasopressins
Vinblastine*
Vincristine
Alkaloids
Bleomycin
Cisplatin
Vasopressins
Vinblastine
Vincristine
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr